• Home
  • »
  • Newsroom
  • »
  • Alexion Provides Statement on Bloomberg Article Entitled, “Alexion S...

Alexion Provides Statement on Bloomberg Article Entitled, “Alexion Says U.S. Health Inspector General Is Part of DOJ Probe”


Friday, July 7, 2017 12:42 pm EDT



Alexion previously disclosed in its 10-Q filing in January 2017 and subsequent SEC filings that in December 2016 the Company received a subpoena from the U.S. Attorneys’ Office for the District of Massachusetts. We are aware that the U.S. Department of Health and Human Services Office of Inspector General is working on this inquiry with the U.S. Attorneys’ Office and the Department of Justice. At this time, Alexion has not received a request for records from the HHS Office of Inspector General pertaining to any other matter.

As a reminder and as previously disclosed, the US Attorneys’ Office requested documents relating generally to our support of 501(c)(3) organizations that provide financial assistance to Medicare patients taking drugs sold by Alexion, Alexion’s provision of free drug to Medicare patients, and Alexion compliance policies and training materials concerning the anti-kickback statute or payments to any 501(c)(3) organization that provides financial assistance to Medicare patients. Other companies have disclosed similar inquiries. We are cooperating with this inquiry and are responding to the subpoena.